Objective Capital Advises Healthcare IT Company on Its Sale to Kinderhook Industries

Posted May 01, 2018 by OCP | Post a Comment

Los Angeles, CA April 24, 2018 — Objective Capital Partners, a leading middle market investment banking firm, is pleased to announce that it served as the exclusive financial advisor to StudyKIK LLC, a rapidly-growing healthcare IT company, on its acquisition by Kinderhook Industries LLC.

“Matt and his team have done a remarkable job in creating a leading patient recruiting platform which is having an enormous impact by making it dramatically more efficient for clinical trial companies to find and engage the high-fit trial volunteers they need to bring new and innovative treatments to market,” said Channing Hamlet, Managing Director of Objective Capital Partners. “We are privileged to have had this opportunity to help StudyKIK and couldn’t be more excited about the future of the company.”

(more…)

Healthcare & Life Sciences, Healthcare, Life Sciences

Objective Capital's David H. Crean Receives The 2018 Health Care Heros Award

Posted February 27, 2018 by OCP | Post a Comment

San Diego Business Journal Health Care Heros Award

San Diego, March 1, 2018 – The San Diego Business Journal’s 2018 Health Care Heroes Awards chose Objective Capital Partners’ David H. Crean, Ph.D. from among the finalists to receive the Health Care Hero Award for Company Executive for his role in healthcare innovation and support.

Leading Objective Capital Partners’ Life Sciences & Healthcare Investment Banking Practice, David leverages more than 20 years of life sciences R&D and corporate development experience. In his Managing Director role, David helps companies secure growth capital, establish strategic partnerships, and achieve exit transactions.

(more…)

News Announcement, David H. Crean, Healthcare, Life Sciences, San Diego

Objective Capital's David H. Crean Named 2017 Thought Leader of the Year

Posted January 29, 2018 by David Crean | Post a Comment

The Alliance of Merger & Acquisition Advisors® (AM&AA)

San Diego, January 30, 2018 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., Managing Director of the firm’s thriving Life Sciences and Healthcare practice, has been selected as the winner of the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA).

The AM&AA recognized that “David’s thought leadership is materially expanding the investment banker’s role in serving life sciences companies and providing these companies with a highly attractive, non-diluting alternative to hard-to-secure venture capital financing.”

“We are observing life sciences and healthcare companies increasing engaging specialized investment banking teams with deep industry experience to gain a strategic advantage,” said Trever Acers, Managing Director at Objective Capital Partners.  “Specialized professionals such as David and his team members at Objective Capital are engaged by experienced Life Sciences executives to significantly improve the value, probability and speed of their M&A, strategic partnering, and growth capital objectives.  David is at the forefront of this change, leveraging his decades of industry experience with best-in-class investment banking capabilities to provide CEO with highly actionable strategic guidance."

(more…)

News Announcement, David H. Crean, Healthcare, Life Sciences, Middle Market, objective capital partners, Alliance of M&A Advisors, Alliance of Mergers & Acquisitions Advisors, Thought Leader, Thought Leader of the Year

Objective Capital’s David H. Crean Named 2017 Finalist for Thought Leader of the Year

Posted December 12, 2017 by David Crean | Post a Comment

San Diego, December 12, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been selected as top five national finalist for the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA). For more information on the Award and the Finalists, please visit http://www.amaaonline.com/thought-leader-of-the-year/

(more…)

David H. Crean, Healthcare, Life Sciences, objective capital partners, Alliance of M&A Advisors, Thought Leader of the Year, Uncategorized

Cagan McAfee Capital Partners Teams with Myles Sherman to Acquire Minimally Invasive Devices

Posted August 16, 2017 by David Crean | Post a Comment

Objective Capital Partners Acted as Financial Advisor to MID

 San Diego, CA- August 21, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Minimally Invasive Devices (MID), privately-held medical device and market leading laparoscopic surgery solutions company, upon its acquisition by Cagan McAfee Capital Partners and seasoned investor/operator, Myles Sherman of Austin, TX. Objective Capital Partners acted as financial advisors to MID.

(more…)

FloShield, Laird Cagan, Mergers & Acqusitions, Minimally Invasive Devices, Cagan McAfee Capital Partners, Healthcare, Laparoscopic Surgery, Life Sciences, Myles Sherman, objective capital partners, Business Sale, Uncategorized, Wayne Poll

ACG San Diego Private Capital Expo: Healthcare

Posted March 10, 2017 by admin | Post a Comment

Objective Capital's David H. Crean to Lead Discussion on Healthcare Topics at March 23rd Event 

San Diego, CA- March 10, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors and Head of its Life Sciences and Healthcare practice, will lead a group of expert panelists at San Diego’s Association of Corporate Growth (ACG) 7th Annual Private Capital Expo on March 23, 2017 from 5:00-8:00 PM. The panel will address Overall Valuation & Activity Levels in Private Capital Markets as part of a breakout session on Healthcare and Life sciences. Additional panel discussions will explore activity in three other dynamic business sectors including Software & Technology, Action Sports, and Industrial & Manufacturing.

(more…)

Capital Financing, Derek Brunelle, George Kenney, ACG San Diego, David H. Crean, Debt Financing, Growth Equity, Healthcare, Jeralin Cordoso, Life Sciences, objective capital partners, Private Capital Expo, Shepherd Ventures, Sheppard Mullin, Silicon Valley Bank, Association for Corporate Growth, Uncategorized

Objective Capital Partner’s Dr. David H. Crean to Lead Discussion on Family Office Trends in HealthCare

Posted October 05, 2016 by admin | Post a Comment

San Diego, CA – October 5, 2016- Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors, has been invited to serve as moderator for a seminar on Healthcare Investments as part of a full-day discussion on Family Office Trends. The event is hosted by Ivy Family Office Network (IvyFON) and will be held on Thursday, October 20th at the offices of Morrison Foerster, 12531 High Bluff Drive, San Diego, CA 92130. A reception will immediately follow the event.

(more…)

Family Office, Healthcare, Life Sciences, objective capital partners, Capital Raise, San Diego, Uncategorized

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com